INIS
patients
100%
brain
88%
cancer
77%
metastases
77%
lung cells
66%
populations
44%
hazards
22%
data
11%
tumors
11%
diseases
11%
mortality
11%
angiogenesis
11%
edema
11%
Nursing and Health Professions
Bevacizumab
88%
Patient
88%
Brain Metastasis
77%
Non Small Cell Lung Cancer
55%
Patient with Cancer
44%
Time
22%
Inpatient
22%
Diseases
11%
Edema
11%
Medicare
11%
Food and Drug Administration
11%
Cancer Registry
11%
Diagnosis
11%
Brain Tumor
11%
Primary Tumor
11%
Electric Potential
11%
Mortality
11%
Survival
11%
Medicine and Dentistry
Bevacizumab
88%
Brain Metastasis
77%
Non Small Cell Lung Cancer
55%
Therapeutic Procedure
33%
Diseases
11%
Angiogenesis
11%
Primary Tumor
11%
Demography
11%
Brain Tumor
11%
Edema
11%
Diagnosis
11%
Hazard Ratio
11%
Predictor
11%
Cancer Registry
11%
Treatment of Non-Small Cell Lung Cancer
11%
Mortality
11%
Survival
11%
Mechanism of Action
11%